BPMC
Ensign Peak Advisors’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.17M | Sell |
32,500
-271,232
| -89% | -$34.8M | 0.01% | 684 |
|
|
2025
Q1 | $26.9M | Buy |
303,732
+28,308
| +10% | +$2.51M | 0.05% | 259 |
|
|
2024
Q4 | $24M | Sell |
275,424
-50,722
| -16% | -$4.42M | 0.04% | 289 |
|
|
2024
Q3 | $30.2M | Buy |
326,146
+19,830
| +6% | +$1.83M | 0.05% | 253 |
|
|
2024
Q2 | $33M | Sell |
306,316
-13,212
| -4% | -$1.42M | 0.06% | 225 |
|
|
2024
Q1 | $30.3M | Buy |
319,528
+94,404
| +42% | +$8.96M | 0.06% | 250 |
|
|
2023
Q4 | $20.8M | Buy |
225,124
+196,984
| +700% | +$18.2M | 0.04% | 293 |
|
|
2023
Q3 | $1.41M | Hold |
28,140
| – | – | ﹤0.01% | 961 |
|
|
2023
Q2 | $1.78M | Hold |
28,140
| – | – | ﹤0.01% | 923 |
|
|
2023
Q1 | $1.27M | Buy |
28,140
+1,600
| +6% | +$72K | ﹤0.01% | 1062 |
|
|
2022
Q4 | $1.16M | Buy |
26,540
+11,500
| +76% | +$504K | ﹤0.01% | 1047 |
|
|
2022
Q3 | $991K | Sell |
15,040
-48,158
| -76% | -$3.17M | ﹤0.01% | 1069 |
|
|
2022
Q2 | $3.19M | Sell |
63,198
-7,426
| -11% | -$375K | 0.01% | 647 |
|
|
2022
Q1 | $4.51M | Buy |
70,624
+2,810
| +4% | +$179K | 0.01% | 619 |
|
|
2021
Q4 | $7.26M | Buy |
67,814
+20,368
| +43% | +$2.18M | 0.01% | 555 |
|
|
2021
Q3 | $4.88M | Buy |
47,446
+16,953
| +56% | +$1.74M | 0.01% | 670 |
|
|
2021
Q2 | $2.68M | Buy |
30,493
+1,000
| +3% | +$88K | 0.01% | 954 |
|
|
2021
Q1 | $2.87M | Buy |
29,493
+7,769
| +36% | +$755K | 0.01% | 894 |
|
|
2020
Q4 | $2.44M | Buy |
21,724
+2,925
| +16% | +$328K | 0.01% | 952 |
|
|
2020
Q3 | $1.74M | Sell |
18,799
-974
| -5% | -$90.3K | ﹤0.01% | 1042 |
|
|
2020
Q2 | $1.54M | Sell |
19,773
-2,417
| -11% | -$188K | ﹤0.01% | 1101 |
|
|
2020
Q1 | $1.3M | Sell |
22,190
-636
| -3% | -$37.2K | ﹤0.01% | 1052 |
|
|
2019
Q4 | $1.83M | Buy |
+22,826
| New | +$1.83M | ﹤0.01% | 1096 |
|